Imprimis recalls epinephrine-lidocaine eye injections due to potential underactive epinephrine. Affected lots may not work properly during eye procedures. Contact FDA for adverse events.
Subpotent: Failing Test Results for Epinephrine
Imprimis NJOF recalls certain epinephrine-lidocaine eye injections because they may contain less active epinephrine than labeled. This could lead to ineffective treatment during eye procedures if used as intended.
The injections may have lower-than-stated epinephrine levels, which could result in ineffective treatment during eye procedures. This is a subpotency issue where the product doesn't meet the required strength for its intended use.
Healthcare professionals using these injections for eye procedures. Patients receiving the injections are at risk if the product fails to deliver proper medication.
Check for the lot number 23APR018 on the packaging. The product is a 1mL single-use intraocular injection with NDC 71384-640-01, compounded on April 24, 2023, and expires April 17, 2024.
Look for lot number 23APR018 on the packaging to confirm if it's affected.
The product may have lower-than-stated epinephrine levels, which could lead to ineffective treatment during eye procedures. It is not recommended for use.
Contact the FDA at www.fda.gov/medwatch or call (800)-FDA-1088 if you experience issues.
The recall does not specify a return or disposal action, so check the product details to confirm if it's affected.
We’ve drafted a message you can send Imprimis NJOF to request your refund or repair — edit it as you like.
Subject: Recall D-0040-2024 — Imprimis NJOF Imprimis NJOF Hello, I own a Imprimis NJOF that is covered by recall D-0040-2024 from Imprimis NJOF. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
